Quest Diagnostics Gains Momentum: Analyst Highlights Strong Business Trends And Growth Opportunities

Truist Securities analyst David S. MacDonald reiterated a Hold rating on Quest Diagnostics Incorporated DGX, raising the price target to $150 from $145.…

Related Keywords

Davids Macdonald , ,Quest Diagnostics Incorporated ,Truist Securities ,News ,Ggregator ,Reaking News ,Uration ,Media ,